Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FCPH9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,664
Award facts
- Contract value 100% obligated
- $38,664.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,664.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois and represents a routine pharmaceutical supply requirement within the Department of Defense's medical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $500 million ceiling value extending through December 31, 2036. The PPV-G GEN V program is a $30.3 billion government-wide pharmaceutical acquisition strategy designed to supply branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders for specialty and routine pharmaceuticals positions it as a critical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCPH9?
SPE2DR26FCPH9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FCPH9 worth?
The government has obligated $38,664 on SPE2DR26FCPH9.
Is contract SPE2DR26FCPH9 an order under another contract?
Yes. SPE2DR26FCPH9 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.
Was contract SPE2DR26FCPH9 competed?
The extent of competition for SPE2DR26FCPH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award